secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK:        0000875320
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0000875320-23-000023
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vertex appoints Michel Lagarde to board as tenth director
---------------------------------------------------------

- Michel Lagarde appointed to Vertex board effective Oct 5, 2023; board expands to 10.
- Lagarde is EVP and COO of Thermo Fisher Scientific; background in pharma services and private equity.
- Received $400,000 RSU award vesting in October 2024; standard non-employee director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/0000875320-23-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/vrtx-20231003.htm
  HTML page:      https://secwatch.observer/filing/0000875320-23-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer